Kimera Labs

Located in South Florida, Kimera® Labs was founded in 2012 and manufactures industry defining stem cell derived exosomes and other biologic products for the clinical and research community. Kimera® Labs operates a manufacturing facility in a 27,000 square foot GMP laboratory in Miramar, Florida. To date, the company's first publicly available isolated exosome product, XoGlo®, has treated over 120,000 patients for a variety of investigational indications. Exosomes have been referenced in numerous peer-reviewed scientific publications and exhibit anti-inflammatory and growth instantiating properties. The success of these therapies has led to a current FDA IND application for post COVID-19 symptom treatment. Since 2012, Kimera® has demonstrated an unmatched approach to quality driven, scalable, GMP nano-particle production.